Devarajan Rathish
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 3
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- Channa Jayasumana (10 shared papers)Sisira Hemananda Siribaddana (8 shared papers)Suneth Buddhika Agampodi (6 shared papers)Nuwan Darshana Wickramasinghe (1 shared paper)Jayanthe Rajapakse (3 shared papers)Kosala Weerakoon (3 shared papers)Rabia Sannam Khan (1 shared paper)Wimalasiri Mewa Uluwattage (1 shared paper)
- Journals
- The Lancet (11 papers)The Lancet Public Health (5 papers)The Lancet Infectious Diseases (5 papers)Nature Medicine (3 papers)Environmental Health and Preventive Medicine (2 papers)
- Partner nations
- Sri LankaUnited StatesAustralia
In The Last Decade
Devarajan Rathish
56 papers receiving 4.9k citations
Devarajan Rathish's Hit Papers
Peers
Comparison fields: 5 of 165
- Applied Microbiology and Biotechnology 383
- Molecular Medicine 382
- Microbiology 128
- Endocrinology 84
- Pollution 187
Countries citing papers authored by Devarajan Rathish
This map shows the geographic impact of Devarajan Rathish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devarajan Rathish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devarajan Rathish more than expected).
Fields of papers citing papers by Devarajan Rathish
This network shows the impact of papers produced by Devarajan Rathish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devarajan Rathish. The network helps show where Devarajan Rathish may publish in the future.
Co-authors
The 8 scholars most cited alongside Devarajan Rathish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1850 |
| 2 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 3 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 4 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 428 |
| 5 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 6 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 7 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 8 | Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 95 |
| 9 | Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 86 |
| 10 | Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 76 |
| 11 | Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 71 |
| 12 | Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 69 |
| 13 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 65 |
| 14 | Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 52 |
| 15 | Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 46 |
| 16 | Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 44 |
| 17 | Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis Hit paper breakdown → | 2025 | 42 |
| 18 | Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 35 |
| 19 | 2017 | 28 | |
| 20 | 2017 | 25 |
About Devarajan Rathish
Devarajan Rathish is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Otorhinolaryngology, Epidemiology and Health, having authored 67 papers that have together received 5.0k indexed citations. Recurring topics across this work include Human-Animal Interaction Studies (3 papers), Pesticide Exposure and Toxicity (3 papers), Antibiotic Use and Resistance (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Rabies epidemiology and control (1 paper), Ear Surgery and Otitis Media (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Zoonotic diseases and public health (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (383 citations), Molecular Medicine (382 citations), Microbiology (128 citations), Endocrinology (84 citations) and Pollution (187 citations). Devarajan Rathish has collaborated with scholars based in Sri Lanka, United States and Australia. Frequent co-authors include Channa Jayasumana, Sisira Hemananda Siribaddana, Suneth Buddhika Agampodi, Nuwan Darshana Wickramasinghe, Jayanthe Rajapakse, Kosala Weerakoon, Rabia Sannam Khan and Wimalasiri Mewa Uluwattage. Their work appears in journals such as The Lancet, The Lancet Public Health, The Lancet Infectious Diseases, Nature Medicine and Environmental Health and Preventive Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.